Bath & Body Works (BBWI) to Release Quarterly Earnings on Thursday

Bath & Body Works (NYSE:BBWI) is anticipated to release its Q1 2026 earnings data before the market opens on Thursday, May 29th. Analysts expect Bath & Body Works to post earnings of $0.42 per share and revenue of $1.42 billion for the quarter. Bath & Body Works has set its Q1 2025 guidance at 0.360-0.430 EPS and its FY 2025 guidance at 3.250-3.600 EPS.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. The business had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. On average, analysts expect Bath & Body Works to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Bath & Body Works Stock Down 6.9%

Shares of NYSE BBWI opened at $31.14 on Thursday. The firm’s 50-day moving average price is $30.19 and its 200-day moving average price is $34.01. The company has a market cap of $6.63 billion, a PE ratio of 7.60, a PEG ratio of 0.92 and a beta of 1.87. Bath & Body Works has a 52-week low of $24.96 and a 52-week high of $52.99.

Bath & Body Works declared that its board has initiated a share repurchase program on Thursday, February 27th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 6.4% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s management believes its stock is undervalued.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.57%. The ex-dividend date of this dividend is Friday, June 6th. Bath & Body Works’s payout ratio is 21.98%.

Wall Street Analyst Weigh In

BBWI has been the topic of a number of recent analyst reports. Morgan Stanley decreased their target price on shares of Bath & Body Works from $49.00 to $43.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 6th. Barclays boosted their price target on shares of Bath & Body Works from $31.00 to $35.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Cowen reaffirmed a “buy” rating on shares of Bath & Body Works in a research note on Thursday, February 27th. The Goldman Sachs Group dropped their price objective on shares of Bath & Body Works from $49.00 to $42.00 and set a “buy” rating for the company in a research note on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Bath & Body Works from $41.00 to $43.00 and gave the stock an “overweight” rating in a research note on Monday. Four research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, Bath & Body Works currently has an average rating of “Moderate Buy” and a consensus price target of $42.56.

Institutional Trading of Bath & Body Works

Hedge funds and other institutional investors have recently modified their holdings of the business. Royal Bank of Canada grew its position in Bath & Body Works by 92.8% in the 1st quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock valued at $1,815,000 after acquiring an additional 28,815 shares in the last quarter. Goldman Sachs Group Inc. grew its position in Bath & Body Works by 15.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock valued at $19,586,000 after acquiring an additional 87,529 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Bath & Body Works by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock valued at $17,063,000 after buying an additional 36,684 shares during the period. Intech Investment Management LLC purchased a new position in shares of Bath & Body Works in the 1st quarter valued at about $1,155,000. Finally, Geneos Wealth Management Inc. boosted its stake in shares of Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after buying an additional 801 shares during the period. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.